Ziad mallat biography of william

Ziad mallat biography of william shakespeare B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. He identified critical counter-regulatory immune mechanisms that tame the development and progression of cardiovascular disease. His basic research activities are complemented by proof-of-concept clinical trials using immune-modulatory therapies in patients with coronary artery disease. External Links British Heart Foundation.

Ziad Mallat

Ziad Mallat

EducationMD, Cardiovascular Diseases, , Pierre and Marie Curie University
PhD, Vascular Biology, Thrombosis and Haemostasis, , Paris Diderot University
ThesisMISE EN EVIDENCE D'UNE MORT CELLULAIRE PROGRAMMEE (APOPTOSE) DU MYOCYTE CARDIAQUE DANS LA DYSPLASIE VENTRICULAIRE DROITE ARYTHMOGENE (DES PATHOLOGIE CARDIOVASCULAIRE)&#;()
InstitutionsUniversity of Cambridge
Inserm
Main interestsatherosclerosis
inflammasome
vascular aneurysms

Ziad Mallat is a French cardiologist.

As a professor of Cardiology at the University of Cambridge, Mallat was the first to identify a major atheroprotective role of regulatory T cells and associated anti-inflammatory cytokines, IL and TGF-β.

Early life and education

Mallat received his medical degree and qualification in cardiovascular diseases from Pierre and Marie Curie University in and his Ph.D.

in Vascular Biology, Thrombosis and Haemostasis from Paris Diderot University in [1]

Career

Mallat was the first to identify a major atheroprotective role of regulatory T cells and associated anti-inflammatory cytokines, IL and TGF-β. Later, he identified selective pathogenic and protective roles for defined B cell and innate lymphoid cell subsets in atherosclerosis and cardiac remodeling following ischemic injury.[1]

During the COVID pandemic, Mallat's research team was shortlisted by the British Heart Foundation for their £30m research prize for his project iMAP.

The aim of his proposal was to create a "Google map" of human atherosclerosis.[2][3] On May 13, , Mallat was one of six faculty members elected to the Academy of Medical Sciences.[4] He was elected for having made "sustained and internationally recognised contributions to our understanding of cardiovascular immunology and atherosclerotic disease and translated these novel findings into clinical trials."[5]

References

  1. ^ ab"Ziad Mallat".

    .

    Ziad mallat biography of william Professor Mallat's Group. Accordingly, I investigated the barriers to care and adverse health outcomes faced by Native Americans in North Carolina. Principal Investigators - Cardiovascular Health. Members Current Scholars Alumni.

    Retrieved May 25,

  2. ^Brierley, Craig (May 20, ). "Could a vaccine protect us against heart attacks?". . Retrieved May 25,
  3. ^"Research team Led by Professor Ziad Mallat Chair of Cardiovascular Medicine at the University of Cambridge short listed for British Heart Foundation £30m research prize".

    Biography of william shakespeare Contact Details. Mallat has published over papers in peer-reviewed journals. PA Email: ziadmallatpa medschl. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice.

    . January 30, Retrieved May 25,

  4. ^"The Academy of Medical Sciences announces new Fellows for ". . May 13, Retrieved May 25,
  5. ^"Professor Ziad Mallat FMedSci". . Retrieved May 25,

External links

Ziad Mallat publications indexed by Google Scholar